Addition of stereotactic body radiotherapy (SBRT) to systemic chemotherapy in locally advanced cholangiocarcinoma (CC) (ABC-07): Results from a randomized phase II trial. Efficacy of disitamab vedotin ...

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study Clinical trials frequently include multiple end points that ...

VeriEQL, a new tool developed by researchers in SFU’s School of Computing Science and collaborators at the University of Michigan, enhances the semantics equivalence verification of complex SQL ...

Plus is worth it if you often hit Free limits and want priority. Pro is for heavy users who need GPT-5.2 Pro and max quotas. Free is powerful, but all tools come with tighter caps. OpenAI introduced ...